Congress tightens fetal tissue research ban, potentially blocking medical research access
H.R. 727 — Prohibiting Abortion Industry’s Lucrative Loopholes Act · Filed by C. Franklin (R-FL) · 12 cosponsors · Introduced Jan 24, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends federal law to expand the definition of 'valuable consideration' in the ban on human fetal tissue sales, making it illegal not just to sell fetal tissue for money, but also to provide it in exchange for any benefit—including waived fees, reduced charges, free services, transportation, storage, or processing. The bill closes what sponsors call 'loopholes' that allow tissue to change hands without direct payment.
Why we flagged it
The bill's operative mechanism is a definitional expansion of what counts as 'valuable consideration' in an existing statutory ban on fetal tissue sales. It does not create a new prohibition but tightens the scope of an existing one by closing perceived loopholes in how 'consideration' is defined.
What the text implies
- Expansion of 'valuable consideration' to include waived or reduced fees may effectively prohibit research institutions from absorbing costs of tissue procurement, processing, or storage—shifting those costs to tissue donors or eliminating research programs entirely.
- Inclusion of 'transportation, implantation, processing, preservation, quality control, or storage' as prohibited consideration may criminalize routine medical logistics, potentially affecting legitimate therapeutic transplantation pipelines.
- The bill does not define 'human fetal tissue' or specify gestational age, leaving ambiguity about whether the restriction applies to all fetal material or only tissue from later-stage pregnancies.
- Enforcement mechanism and penalties are not stated in the bill text; the effect depends on existing § 498B enforcement provisions, which are not quoted here.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill restricts access to fetal tissue for medical research and transplantation, which may reduce research opportunities and therapeutic options for patients with certain diseases (Parkinson's, diabetes, spinal injury). However, it also enforces a longstanding federal prohibition against commodification of human tissue and may protect against exploitation of pregnant people or tissue donors. The net effect on ordinary citizens depends on the weight given to research access versus tissue-commo
Named in the bill
Public Health Service Act, 42 U.S.C. § 498B, fetal tissue research institutions, tissue banks, medical transplant programs
Where it stands
12 cosponsors: 12 Republicans.
- Jan 24, 2025 — Introduced · Congress.gov: “Introduced in House”
- Jan 24, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (937 characters) on Aug 31, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Congress tightens fetal tissue research ban, potentially blocking medical research access” QuorumCivic. https://share.quorumcivic.app/bill/119/hr727 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.